143 related articles for article (PubMed ID: 33179136)
1. The non-steroidal anti-inflammatory drug salsalate provides safe and effective control of mucositis-unrelated pain during autologous and allogeneic hematopoietic stem cell transplantation.
Trifilio S; Gordon L; Rubin H; Grosshans N; Mehta J
Support Care Cancer; 2021 Jul; 29(7):3643-3648. PubMed ID: 33179136
[TBL] [Abstract][Full Text] [Related]
2. Impact of Oral and Gastrointestinal Mucositis on Body Weight Alterations during Hematopoietic Stem Cell Transplantation.
Eduardo FP; Bezinelli LM; Gobbi MF; Pereira AZ; Vogel C; Hamerschlak N; Corrêa L
Nutr Cancer; 2018; 70(2):241-248. PubMed ID: 29278934
[TBL] [Abstract][Full Text] [Related]
3. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
[TBL] [Abstract][Full Text] [Related]
4. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Pretransplant Multidrug-Resistant Gram-Negative Colonization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation.
Forcina A; Lorentino F; Marasco V; Oltolini C; Marcatti M; Greco R; Lupo-Stanghellini MT; Carrabba M; Bernardi M; Peccatori J; Corti C; Ciceri F
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1476-1482. PubMed ID: 29501780
[TBL] [Abstract][Full Text] [Related]
6. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
[TBL] [Abstract][Full Text] [Related]
7. Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation.
Sengeløv H; Petersen PM; Fog L; Schmidt M; Specht L
Bone Marrow Transplant; 2019 Aug; 54(8):1369-1371. PubMed ID: 30718801
[No Abstract] [Full Text] [Related]
8. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
[TBL] [Abstract][Full Text] [Related]
9. Early and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 years.
Hierlmeier S; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2018; 13(10):e0204914. PubMed ID: 30325953
[TBL] [Abstract][Full Text] [Related]
10. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
11. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
12. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
[TBL] [Abstract][Full Text] [Related]
14. Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes.
Al Mulla N; Kahn JM; Jin Z; Qureshi M; Karamehmet E; Yoon-Jeong Kim G; Levinson AL; Bhatia M; Garvin JH; George D; Kung AL; Satwani P
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1525-1530. PubMed ID: 27223110
[TBL] [Abstract][Full Text] [Related]
15. Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
Kebriaei P; Bassett R; Lyons G; Valdez B; Ledesma C; Rondon G; Oran B; Ciurea S; Alousi A; Popat U; Patel K; Ahmed S; Olson A; Bashir Q; Shah N; Jones R; Marin D; Rezvani K; Nieto Y; Khouri I; Qazilbash M; Hosing C; Shpall E; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2017 Feb; 23(2):285-292. PubMed ID: 27816651
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation.
Fernandez HF; Tran HT; Albrecht F; Lennon S; Caldera H; Goodman MS
Biol Blood Marrow Transplant; 2002; 8(9):486-92. PubMed ID: 12374453
[TBL] [Abstract][Full Text] [Related]
17. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Ishida S; Doki N; Shingai N; Yoshioka K; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2016 Jun; 95(7):1145-50. PubMed ID: 27079957
[TBL] [Abstract][Full Text] [Related]
18. The relationship between oral mucositis and levels of pro-inflammatory cytokines in serum and in gingival crevicular fluid in allogeneic stem cell recipients.
Legert KG; Tsilingaridis G; Remberger M; Ringdèn O; Heimdahl A; Yucel-Lindberg T; Dahllöf G
Support Care Cancer; 2015 Jun; 23(6):1749-57. PubMed ID: 25433441
[TBL] [Abstract][Full Text] [Related]
19. Supersaturated Calcium Phosphate Rinse in Prevention and Treatment of Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplant.
Bhatt N; Naithani R; Gupta SK
Exp Clin Transplant; 2017 Oct; 15(5):567-570. PubMed ID: 28229803
[TBL] [Abstract][Full Text] [Related]
20. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
